Esperion Therapeutics (ESPR) P/S (2019 - 2026)
Esperion Therapeutics (ESPR) P/S from Apr 1, 2019 to Jul 13, 2026. The TTM Esperion Therapeutics (ESPR) P/S is 1.91. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Esperion Therapeutics (ESPR)
| Year | P/S | Change |
|---|---|---|
| 2026 | 1.91 | +3.73% |
| 2025 | 1.84 | +42.76% |
| 2024 | 1.29 | -60.30% |
| 2023 | 3.25 | -44.56% |
| 2022 | 5.86 | +247.68% |
| 2021 | 1.69 | -47.03% |
| 2020 | 3.18 | -71.20% |
| 2019 | 11.05 | N/A |
Comparison Esperion Therapeutics (ESPR) P/S with competitors
Esperion Therapeutics (ESPR) P/S is 1.91.